Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ICCC
- Price
- 6.24
- Stock movement down
- -0.36 (-5.45%)
- Company name
- ImmuCell Corporation
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 56.45M
- Ent value
- 68.49M
- Price/Sales
- 2.03
- Price/Book
- 1.89
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 24.29
- Forward P/E
- -
- PEG
- -
- EPS growth
- 6.81%
- 1 year return (CAGR)
- 24.80%
- 3 year return (CAGR)
- -5.14%
- 5 year return (CAGR)
- -11.10%
- 10 year return (CAGR)
- -1.95%
Last updated: 2026-03-04
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ICCC does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 24.29 |
| Price to OCF | 28.37 |
| Price to FCF | 78.91 |
| Price to EBITDA | 11.37 |
| EV to EBITDA | 13.79 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.03 |
| Price to Book | 1.89 |
| EV to Sales | 2.47 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 9.05M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 20.02M |
| Gross profit (TTM) | 8.53M |
| Operating income (TTM) | 1.71M |
| Net income (TTM) | 1.81M |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 42.64% |
| Operating margin (TTM) | 8.53% |
| Profit margin (TTM) | 9.04% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.81M |
| Net receivables | 0.00 |
| Total current assets | 13.07M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 42.53M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 0.00 |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 1.99M |
| Capital expenditures (TTM) | 1.08M |
| Free cash flow (TTM) | 914.62K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | 4.25% |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 6.59 |
| Daily high | 6.59 |
| Daily low | 6.20 |
| Daily Volume | 22K |
| All-time high | 11.88 |
| 1y analyst estimate | 14.00 |
| Beta | 0.19 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ICCC | S&P500 | |
| Current price drop from All-time high | -47.47% | -1.82% |
| Highest price drop | -93.56% | -56.47% |
| Date of highest drop | 11 Mar 1991 | 9 Mar 2009 |
| Avg drop from high | -55.45% | -10.84% |
| Avg time to new high | 213 days | 12 days |
| Max time to new high | 2324 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
56.45M
Marketcap category
Small-cap
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments: Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Employees
77
Website
Investor relations
-
SEC filings
CEO
Michael F. Brigham
Country
USA
City
Portland
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page